Related Experiment Video
Updated: Jun 27, 2025

Elevated Plus Maze for Mice
Published on: December 22, 2008
Impact of Abl2/Arg deficiency on anxiety and depressive behaviors in mice
Xiaojuan Yao1, Ruiying Chen1, Hongting Chen1
1Institute of Science and Technology for Brain-Inspired Intelligence, Behavioral and Cognitive Neuroscience Center, Fudan University, Shanghai 200433, China; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Ministry of Education, Behavioral and Cognitive Neuroscience Center, Fudan University, Shanghai 200433, China.
Abstract:
Abl2/Arg (ABL-related gene) is a member of the Abelson family of nonreceptor tyrosine kinases, known for its role in tumor progression, metastasis, tissue injury responses, inflammation, neural degeneration, and other diseases. In this study, we developed Abl2/Arg knockout (abl2-/-) mice to explore its impact on sensory/motor functions and emotion-related behaviors. Our findings show that abl2-/- mice exhibit normal growth and phenotypic characteristics, closely resembling their wild-type (WT) counterparts. Behavioral tests, including the elevated plus maze, marble-burying behavior test, and open field test, indicated pronounced anxiety-like behaviors in abl2-/- mice compared to WT mice. Furthermore, in the tail suspension test, abl2-/- mice showed a significant decrease in mobility time, suggesting depressive-like behavior. Conversely, in the Y-maze and cliff avoidance reaction tests, no notable differences were observed between abl2-/- and WT mice, suggesting the absence of working memory deficits and impulsivity in abl2-/- mice. Proteomic analysis of the hippocampus in abl2-/- mice highlighted significant alterations in proteins related to anxiety and depression, especially those associated with the GABAergic synapse in inhibitory neurotransmission. The expression of Gabbr2 was significantly reduced in the hippocampus of abl2-/- compared to WT mice, and intraperitoneal treatment of GABA receptor agonist Gaboxadol normalized anxiety/depression-related behaviors of abl2-/- mice. These findings underscore the potential role of Abl2/Arg in influencing anxiety and depressive-like behaviors, thereby contributing valuable insights into its broader physiological and pathological functions.
Insights
Abl2/Arg knockout mice exhibit anxiety and depressive-like behaviors, linked to altered GABAergic neurotransmission in the hippocampus. Gaboxadol treatment normalized these behaviors, highlighting Abl2/Arg
Area of Science:
- Neuroscience
- Molecular Biology
- Behavioral Genetics
Background:
- Abl2/Arg, a nonreceptor tyrosine kinase, is implicated in various diseases including cancer and neurodegeneration.
- Its precise role in regulating emotion-related behaviors remains largely unexplored.
Purpose of the Study:
- To investigate the impact of Abl2/Arg deficiency on sensory/motor functions and emotion-related behaviors using knockout mice.
- To elucidate the molecular mechanisms underlying any observed behavioral changes, focusing on hippocampal function.
Main Methods:
- Development and characterization of Abl2/Arg knockout (abl2-/-) mice.
- Behavioral assessments including elevated plus maze, marble-burying, open field, tail suspension, Y-maze, and cliff avoidance tests.
- Proteomic analysis of hippocampal tissue and targeted molecular interventions with GABA receptor agonists.
Main Results:
- abl2-/- mice displayed significant anxiety- and depressive-like behaviors but normal sensory/motor functions, working memory, and impulsivity.
- Proteomic analysis revealed altered hippocampal proteins involved in GABAergic neurotransmission, with reduced Gabbr2 expression in abl2-/- mice.
- Administration of Gaboxadol, a GABA receptor agonist, ameliorated the anxiety- and depressive-like behaviors in abl2-/- mice.
Conclusions:
- Abl2/Arg plays a crucial role in modulating anxiety and depressive-like behaviors, independent of sensory/motor functions.
- Deficiency in Abl2/Arg impacts inhibitory neurotransmission via the GABAergic system in the hippocampus.
- Targeting the GABAergic system presents a potential therapeutic strategy for Abl2/Arg-associated behavioral dysregulation.

